EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study

Pilar García-Alfonso, Paula Jimenez-Fonseca, Javier Soto-Alsar, Iosune Baraibar, Cristina Santos, Adelaida La Casta, Ismael Ghanem, Gema Pulido Cortijo, Axel Mariño Méndez, Roberto Pazo-Cid, Ruth Vera, Marcos Melián und 10 weitere

The Oncologist · 2025

DOI: 10.1093/oncolo/oyae300 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Oncologist, 2025. Verfasst von Pilar García-Alfonso und 21 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universi…. Hauptthemen laut MEDLINE: COVID-19, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Treatment of Digestive Tumors (TTD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The initial SARS-CoV-2 pandemic wave in Spain in 2020 precipitated significant paradigm shifts in gastrointestinal oncology patient management. This study captures the “Zeitgeist” of this period by analyzing adaptive strategies, treatment modifications, and survival outcomes, leveraging a 3-year follow-up perspective to extract insights from this unprecedented experience.

Methods

We conducted a multicenter, retrospective cohort study utilizing the RETUD-TTD registry, encompassing 703 patients across 19 Spanish centers in April 2020. We evaluated alterations in clinical practice, therapeutic approaches, coronavirus disease 2019 (COVID-19)-related impacts, and patient survival. A Bayesian hierarchical model was employed to identify potential regional-specific frailties.

Results

The peak of the pandemic in April 2020 catalyzed substantial shifts in oncological care delivery. Outpatient consultations decreased by 13%, with a notable selection bias toward cases with more favorable prognostic indicators. Multidisciplinary tumor board discussions were significantly curtailed (eg, mean monthly colorectal cancer cases discussed was reduced from 40 to 23), compromising qualitative care measures. This occurred concurrently with an average of over 3 oncologists per center on medical leave. Contrary to initial concerns, the healthcare system demonstrated remarkable resilience. The majority of patients received standard-of-care therapies with regulatory approval, albeit with regimen modifications in 15% of cases. These adaptations included extended dosing intervals, dose intensity modulations, and transitions to oral formulations while maintaining unexpectedly stable long-term survival outcomes. The Bayesian frailty model detected minimal unmeasured prognostic factors related to geographic location, and the type of pandemic-induced adaptation did not significantly impact survival. The model revealed that coronavirus disease 2019’s impact was less pronounced than other core prognostic variables.

Conclusions

The decentralized Spanish healthcare system exhibited substantial robustness in managing pre-pandemic diagnosed gastrointestinal malignancies, despite asymmetrical, and occasionally severe organizational disruptions. The insights gleaned from this experience could inform future crisis preparedness strategies and optimize care provision during subsequent public health emergencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Gastrointestinal NeoplasmsAgedFemaleHumansMaleMiddle AgedBayes TheoremFollow-Up StudiesPandemicsRegistriesRetrospective StudiesSARS-CoV-2SpainCohort Studies

Stichwörter der Autor:innen

PANDORA-TTD20RETUD registrySpaincoronavirus disease 2019gastrointestinal cancerspatial frailties

Autor:innen und Institutionen

  • Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense, Madrid, 28007, Spain.
  • Medical Oncology Department, Hospital Universitario Central de Asturias (HUCA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, 33011, Spain.
  • Medical Oncology Department, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autónoma de Barcelona, CIBERONC, Barcelona, 08035, Spain.
  • Medical Oncology Department, Institut Català d'Oncologia (ICO), Translational Research Laboratory, ICO-Bellvitge Biomedical Research Institute (IDIBELL)-CIBERONC, Barcelona, 08908, Spain.
  • Medical Oncology Department, Hospital Universitario de Donostia, Guipúzcoa, 20014, Spain.
  • Medical Oncology Department, Hospital Universitario La Paz, Madrid, 28046, Spain.

ORCID-Profile: Ana Fernández Montes, Alberto Carmona-Bayonas

Förderung

  • Treatment of Digestive Tumors (TTD)

Zitieren

APA

García-Alfonso, P., Jimenez-Fonseca, P., Soto-Alsar, J., Baraibar, I., Santos, C., La Casta, A., Ghanem, I., Pulido Cortijo, G., Mariño Méndez, A., Pazo-Cid, R., Vera, R., Melián, M., Alcaide, J., Graña, B., Páez, D., Gallego, I., Lobo, M., Borregón, M., Fernández Montes, A., …, & Aranda, E. (2025). Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study. The Oncologist. https://doi.org/10.1093/oncolo/oyae300

Vancouver

García-Alfonso P, Jimenez-Fonseca P, Soto-Alsar J, Baraibar I, Santos C, La Casta A, et al. Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study. The Oncologist. 2025. doi:10.1093/oncolo/oyae300

BibTeX
@article{GarcaAlfonso2025,
  author = {García-Alfonso, Pilar and Jimenez-Fonseca, Paula and Soto-Alsar, Javier and Baraibar, Iosune and Santos, Cristina and La Casta, Adelaida and Ghanem, Ismael and Pulido Cortijo, Gema and Mariño Méndez, Axel and Pazo-Cid, Roberto and Vera, Ruth and Melián, Marcos and Alcaide, Julia and Graña, Begoña and Páez, David and Gallego, Inmaculada and Lobo, Miriam and Borregón, Miguel and Fernández Montes, Ana and Martínez de Castro, Eva and Carmona-Bayonas, Alberto and Aranda, Enrique},
  title = {Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyae300}
}
Kostenlos starten →